Healthcare ❯Pharmaceuticals

Cancer Treatment

Keytruda Innovation Clinical Trials Radioconjugates Drug Approval Gastrointestinal Stromal Tumors Personalized Cancer Treatment FDA Approval

AstraZeneca Under Chinese Compliance Probe; Lung Cancer Drug Trial Results Disappoint

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Merck to Acquire EyeBio for Up to $3 Billion

AstraZeneca to Invest $1.5 Billion in Singapore Cancer Drug Plant

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline